CTGE2_HUMAN - dbPTM
CTGE2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CTGE2_HUMAN
UniProt AC Q96RT6
Protein Name cTAGE family member 2
Gene Name CTAGE1
Organism Homo sapiens (Human).
Sequence Length 745
Subcellular Localization Membrane
Single-pass membrane protein .
Protein Description
Protein Sequence MRPDSHPYGFPWELVIRAAVAGFFAVLFLWRSFRSVTSRLYVRREKKFAVALSGLIEEKCKLLEKFSLVQKEYEGYEVESSLKNASFEKEATEAQSLEATCEKLNRFNSELVHEILCLEKELKEEKSKHSEQNELMADISKRIQSLEDESKSLKSQVAEAKMTFKRFQANEERLEIEIQDAWKENSELQESQKQLLQEAEVWKEQVSELIKQKRTFEDSKVHAEQVLNDKENHIKTLTERLLKMKDGVAMLEEDVTDDDNLELEMNSESEDGAYLDNPPKGALKKLIHAAKLNASLKTLEGERNQIYIQLSEVDKTKEELTEHIKNLQTEQASLQSENTHFESENQKLQQKLKVMTELYQENEMKLYRKLIVEEKCRLEKEEKLSKVDEMISHATEELETYRKRAKDLKEFEKTIHFYQKKIILHEKKAHDNWSAAWTAERNLNDLRKENAHNRQKLTEIEFKIKLLEKDPYGLDVPNTAFGRQHSPYGPSPLGWPSSETRASLYPPTLLEGPLRLSPLLPRGGGRGSRGPGNPPDHQITKERGESSCDRLTDPHRAPSDAGPLAPPWEQDYRMMFPPPGQSYPDSALPPQRQDRFYSNCARLSGPAELRSFNMPSLDKMDGSMPSEMESSRNDTKDNLGNLKVPDSSLPAENEATGPGFVPPPLAPIRGLLFPVDTRGPFIRRGPPFPPPPPGTVFGASPDYFSPRDVPGPPRAPFAMRNVYLPRGFLPYRPPRPAFFPPAPTF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MRPDSHPYGFPW
---CCCCCCCCCCCH
29.1023401153
8PhosphorylationMRPDSHPYGFPWELV
CCCCCCCCCCCHHHH
26.4423401153
35PhosphorylationFLWRSFRSVTSRLYV
HHHHHHHHHHHHHHH
27.95-
53PhosphorylationKKFAVALSGLIEEKC
HHHHHHHHHHHHHHH
23.0918452278
65UbiquitinationEKCKLLEKFSLVQKE
HHHHHHHHHCCHHHH
39.98-
67PhosphorylationCKLLEKFSLVQKEYE
HHHHHHHCCHHHHHC
38.4029396449
73PhosphorylationFSLVQKEYEGYEVES
HCCHHHHHCCCCCCH
22.9928796482
76PhosphorylationVQKEYEGYEVESSLK
HHHHHCCCCCCHHHH
12.5928796482
80PhosphorylationYEGYEVESSLKNASF
HCCCCCCHHHHCCCH
46.2630108239
81PhosphorylationEGYEVESSLKNASFE
CCCCCCHHHHCCCHH
29.8330108239
86PhosphorylationESSLKNASFEKEATE
CHHHHCCCHHHHHHH
43.2530108239
92PhosphorylationASFEKEATEAQSLEA
CCHHHHHHHHHHHHH
32.7130108239
96PhosphorylationKEATEAQSLEATCEK
HHHHHHHHHHHHHHH
34.9121815630
103UbiquitinationSLEATCEKLNRFNSE
HHHHHHHHHHHCCHH
53.89-
109PhosphorylationEKLNRFNSELVHEIL
HHHHHCCHHHHHHHH
29.6029396449
140PhosphorylationNELMADISKRIQSLE
HHHHHHHHHHHHHHH
19.2122210691
145PhosphorylationDISKRIQSLEDESKS
HHHHHHHHHHHHHHH
31.2122210691
150PhosphorylationIQSLEDESKSLKSQV
HHHHHHHHHHHHHHH
39.6122210691
152PhosphorylationSLEDESKSLKSQVAE
HHHHHHHHHHHHHHH
50.7622210691
154UbiquitinationEDESKSLKSQVAEAK
HHHHHHHHHHHHHHH
46.03-
267PhosphorylationNLELEMNSESEDGAY
CCEEEECCCCCCCCC
40.9824275569
269PhosphorylationELEMNSESEDGAYLD
EEEECCCCCCCCCCC
40.5924275569
291UbiquitinationKKLIHAAKLNASLKT
HHHHHHHHHCHHHHH
42.95-
297UbiquitinationAKLNASLKTLEGERN
HHHCHHHHHHHCCCC
48.87-
392PhosphorylationSKVDEMISHATEELE
HHHHHHHHHHHHHHH
13.0325907765
395PhosphorylationDEMISHATEELETYR
HHHHHHHHHHHHHHH
25.2725907765
400PhosphorylationHATEELETYRKRAKD
HHHHHHHHHHHHHHH
41.0525907765
401PhosphorylationATEELETYRKRAKDL
HHHHHHHHHHHHHHH
12.5425907765
414PhosphorylationDLKEFEKTIHFYQKK
HHHHHHHHHHHHHHH
16.7019413330
427UbiquitinationKKIILHEKKAHDNWS
HHHEEEEHHCCCCHH
44.5021890473
458PhosphorylationAHNRQKLTEIEFKIK
CCCHHHHHHEEHHHH
41.7924114839
486PhosphorylationTAFGRQHSPYGPSPL
CCCCCCCCCCCCCCC
16.1028302921
488PhosphorylationFGRQHSPYGPSPLGW
CCCCCCCCCCCCCCC
44.6919845377
491PhosphorylationQHSPYGPSPLGWPSS
CCCCCCCCCCCCCCH
28.5222496350
517PhosphorylationLEGPLRLSPLLPRGG
CCCCCEECCCCCCCC
13.6823403867
546PhosphorylationITKERGESSCDRLTD
CCHHHCCCCHHCCCC
38.8125850435
547PhosphorylationTKERGESSCDRLTDP
CHHHCCCCHHCCCCC
18.7425850435
552PhosphorylationESSCDRLTDPHRAPS
CCCHHCCCCCCCCCC
48.6725850435
582PhosphorylationMFPPPGQSYPDSALP
CCCCCCCCCCCCCCC
44.5424275569
583PhosphorylationFPPPGQSYPDSALPP
CCCCCCCCCCCCCCH
11.8124275569
604PhosphorylationYSNCARLSGPAELRS
HHCCHHCCCCHHHHH
36.8623401153
611PhosphorylationSGPAELRSFNMPSLD
CCCHHHHHCCCCCHH
33.3323927012
616PhosphorylationLRSFNMPSLDKMDGS
HHHCCCCCHHCCCCC
38.1323927012
623PhosphorylationSLDKMDGSMPSEMES
CHHCCCCCCCHHHHH
24.2123401153
626PhosphorylationKMDGSMPSEMESSRN
CCCCCCCHHHHHCCC
40.7229083192
630PhosphorylationSMPSEMESSRNDTKD
CCCHHHHHCCCCCCC
33.0330576142
631PhosphorylationMPSEMESSRNDTKDN
CCHHHHHCCCCCCCC
23.0722115753
635PhosphorylationMESSRNDTKDNLGNL
HHHCCCCCCCCCCCC
43.7922115753
647PhosphorylationGNLKVPDSSLPAENE
CCCCCCCCCCCCCCC
27.9222210691
648PhosphorylationNLKVPDSSLPAENEA
CCCCCCCCCCCCCCC
45.8322210691
677PhosphorylationGLLFPVDTRGPFIRR
CCEEECCCCCCCHHC
37.4522210691

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CTGE2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CTGE2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CTGE2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of CTGE2_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CTGE2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-414, AND MASSSPECTROMETRY.

TOP